Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Open in API
Filings indexed 1,332 across all filing types
Latest filing 2012-09-06 Director's Dealing
Country DK Denmark
Listing CO AMBU

About Ambu

https://www.ambu.com

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document is a formal notification dated September 6, 2012, reporting a transaction involving shares of Ambu A/S. The text explicitly states it is reporting transactions in shares ('Indberetning af transaktioner med aktier') made by a board member ('Bestyrelsesmedlem') named Mikael Worning, detailing the date, nature (Purchase of shares - 'Køb af aktier'), quantity, and price. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The appropriate code is DIRS.
2012-09-06 English
Regulatory Filings 2012
Regulatory Filings
2012-08-31 Danish
Regulatory Filings 2012
Regulatory Filings
2012-08-31 English
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document is a short notification written in Danish, referencing the Danish Securities Trading Act ('Værdipapirhandelslovens § 28 a, stk. 5'). It details a transaction involving shares of Ambu A/S by an executive (President & CEO, Lars Marcher). Specifically, it reports the 'Køb af aktier' (Purchase of shares) by an insider on a specific date. This perfectly matches the definition of Director's Dealing (insider trades). Matching against definitions: - 10-K/IR/ER/AR: Not a full financial report. - DIV/CAP/SHA: Not about dividends, general financing, or capital structure changes. - DIRS (Director's Dealing): Explicitly reports personal share transactions by directors/executives. This is the correct classification.
2012-08-23 Danish
Director's Dealing 2012
Director's Dealing Classification · 100% confidence The document explicitly states it is reporting information received in pursuance of Section 28 a, Subsection 5 of the Danish Securities Trading Act. The content details a transaction involving a company executive (Lars Marcher, President & CEO) purchasing shares of the company (Ambu A/S). This structure—reporting a transaction by a director or senior executive—directly matches the definition of a Director's Dealing report. The appropriate code is DIRS.
2012-08-23 English
M&A Activity 2012
M&A Activity Classification · 99% confidence The document details the completion of an acquisition (Ambu acquiring Unomedical's electrode and diathermy business), outlines the assets acquired, the expected impact on revenue and EBIT for FY 2011/12 and FY 2012/13, and provides contact information. This content strongly relates to corporate restructuring, financing activities, or significant business transactions that impact capital structure or future performance, but it is not a standard regulatory report (like 10-K or IR). It is an announcement regarding a major transaction. Among the provided codes, 'Capital/Financing Update' (CAP) is the closest fit for a significant M&A announcement that details financial impact, although 'M&A Activity' (TAR) is also relevant. Since the text focuses heavily on the financial implications (revenue/EBIT adjustments) following the transaction completion, and it is not a formal tender offer document, CAP is a reasonable classification for a material corporate event update, or TAR if focusing purely on the M&A aspect. Given the detailed financial outlook adjustment, I will classify this as a Capital/Financing Update (CAP) as it directly addresses changes to the company's financial structure and outlook resulting from the transaction. If TAR was strictly for the initial bid/offer, CAP covers the resulting financial update.
2012-05-31 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.